Detalhe da pesquisa
1.
Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
Rheumatology (Oxford)
; 59(9): 2455-2461, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960053
2.
Pro-inflammatory S100A11 is elevated in inflammatory myopathies and reflects disease activity and extramuscular manifestations in myositis.
Cytokine
; 116: 13-20, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684913
3.
Effect of CTLA4-Ig (abatacept) treatment on T cells and B cells in peripheral blood of patients with polymyositis and dermatomyositis.
Scand J Immunol
; 89(1): e12732, 2019 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-30451307
4.
Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry.
Clin Exp Rheumatol
; 37(2): 342-343, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30620295
5.
Clinical trials roundup in idiopathic inflammatory myopathies.
Curr Opin Rheumatol
; 23(6): 605-11, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21926626
6.
Serum levels of B-cell activating factor of the TNF family (BAFF) correlate with anti-Jo-1 autoantibodies levels and disease activity in patients with anti-Jo-1positive polymyositis and dermatomyositis.
Arthritis Res Ther
; 20(1): 158, 2018 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053824
7.
Treatment-resistant inflammatory myopathy.
Best Pract Res Clin Rheumatol
; 24(3): 427-40, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20534375